In this issue:
Midostaurin vs. cladribine in advanced systemic mastocytosis
Thrombocytopenia during obinutuzumab + bendamustine for follicular lymphoma
Interferon-α vs. hydroxycarbamide in polycythaemia vera/essential thrombocythaemia
Gilteritinib for treating relapsed/refractory FLT3-mutated AML
CAR T-cell therapy for B-cell ALL with CNS involvement
Deficient T-cell response to COVID-19 vaccines in allogeneic SCT survivors
Thalidomide-cyclophosphamidedexamethasone for recurrent/refractory Langerhans cell histiocytosis
Functional decline after allogeneic SCT in older adults
Long-term survival after SCT for sickle cell disease
Post-relapse survival in Waldenström macroglobulinaemia not responding to SCT
Please login below to download this issue (PDF)